AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. RENB
  4. [PRE 14A] Renovaro Inc. Preliminary Proxy Statement

[PRE 14A] Renovaro Inc. Preliminary Proxy Statement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
PRE 14A

Filing content is currently unavailable.

Source:

Stock RENB logo
Renovaro

NASDAQ:RENB

RENB Rankings

#7586 Ranked by Market Cap
N/A Ranked by Dividends

RENB Latest News

Aug 8, 2025
Renovaro Inc. (NASDAQ: RENB) Mentioned in AG真人官方ClearDefense Article on AI and Biodefense Risks
Jul 28, 2025
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector
Jul 17, 2025
Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy
Jul 9, 2025
Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives
Jun 30, 2025
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

RENB Latest SEC Filings

Aug 6, 2025
[8-K] Renovaro Inc. Reports Material Event
Jul 30, 2025
[DEF 14A] Renovaro Inc. Definitive Proxy Statement
Jul 25, 2025
[8-K] Renovaro Inc. Reports Material Event
Jul 14, 2025
[8-K] Renovaro Inc. Reports Material Event
Jul 10, 2025
[SCHEDULE 13D/A] Renovaro Inc. SEC Filing

RENB Stock Data

55.49M
146.15M
36.71%
15.44%
0.57%
Biotechnology
Pharmaceutical Preparations
United States
SUITE 906 LOS ANGELES